The company that will revolutionize the way Americans shop on the internet through an intelligent system powered by “artificial intelligence” ...

Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis and other ...